DD238235A5 - Verfahren zur herstellung von ringkondensierten pyrazolo/3,4-d/-pyridin-3-on-derivaten - Google Patents

Verfahren zur herstellung von ringkondensierten pyrazolo/3,4-d/-pyridin-3-on-derivaten Download PDF

Info

Publication number
DD238235A5
DD238235A5 DD85278380A DD27838085A DD238235A5 DD 238235 A5 DD238235 A5 DD 238235A5 DD 85278380 A DD85278380 A DD 85278380A DD 27838085 A DD27838085 A DD 27838085A DD 238235 A5 DD238235 A5 DD 238235A5
Authority
DD
German Democratic Republic
Prior art keywords
lower alkyl
disubstituted
mono
phenyl
substituted
Prior art date
Application number
DD85278380A
Other languages
German (de)
English (en)
Inventor
Yokoyama
Original Assignee
����`��@���k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ����`��@���k�� filed Critical ����`��@���k��
Publication of DD238235A5 publication Critical patent/DD238235A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DD85278380A 1984-07-09 1985-07-08 Verfahren zur herstellung von ringkondensierten pyrazolo/3,4-d/-pyridin-3-on-derivaten DD238235A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62870384A 1984-07-09 1984-07-09

Publications (1)

Publication Number Publication Date
DD238235A5 true DD238235A5 (de) 1986-08-13

Family

ID=24519969

Family Applications (1)

Application Number Title Priority Date Filing Date
DD85278380A DD238235A5 (de) 1984-07-09 1985-07-08 Verfahren zur herstellung von ringkondensierten pyrazolo/3,4-d/-pyridin-3-on-derivaten

Country Status (18)

Country Link
EP (1) EP0168350B1 (el)
JP (1) JPS6140285A (el)
AT (1) ATE75744T1 (el)
AU (1) AU584906B2 (el)
CA (1) CA1263651A (el)
DD (1) DD238235A5 (el)
DE (1) DE3585973D1 (el)
DK (1) DK168952B1 (el)
ES (2) ES8703462A1 (el)
FI (1) FI80695C (el)
GR (1) GR851685B (el)
HU (1) HU198929B (el)
IE (1) IE58743B1 (el)
IL (1) IL75745A (el)
NO (1) NO163056C (el)
NZ (1) NZ212669A (el)
PT (1) PT80777B (el)
ZA (1) ZA855126B (el)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0223420A1 (en) * 1985-10-18 1987-05-27 Shionogi & Co., Ltd. Condensed imidazopyridine derivatives

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2566405B1 (fr) * 1984-06-25 1986-09-26 Roussel Uclaf Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2 par une fonction aminee, leur preparation, leur application comme medicaments, les compositions les renfermant et les intermediaires nouveaux obtenus
DE3781249T2 (de) * 1986-11-25 1992-12-17 Ciba Geigy Ag Einige cycloalka(b)pyrazolo(3,4-d)pyridin-3-on-derivate.
DE3888864T2 (de) * 1987-04-09 1994-10-13 Du Pont Insektizide substituierte Indazole.
US5378848A (en) * 1992-02-12 1995-01-03 Shionogi & Co., Ltd. Condensed imidazopyridine derivatives
GB9713707D0 (en) * 1997-06-27 1997-09-03 Merck Sharp & Dohme Therapeutic agents
US6957741B2 (en) 2001-08-07 2005-10-25 Manfred Franz Axel Freissle Screening arrangement
AR127972A1 (es) * 2021-12-17 2024-03-13 Pi Industries Ltd Novedosos compuestos de piridina carboxamida bicíclica sustituida fusionada para combatir hongos fitopatogénicos

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY1357A (en) * 1979-06-21 1987-08-07 Ciba Geigy Ag Pyrazolo-quinolines, processes for their production, pharmaceutical compositions containing them and their therapeutical use
US4524146A (en) * 1982-12-08 1985-06-18 Ciba-Geigy Corporation Certain -2-heterocycle substituted pyrazoloquinolines
US4479955A (en) * 1983-01-10 1984-10-30 Ciba-Geigy Corporation Heterocycle-fused pyrazolo[3,4-d]pyridin-3-ones as benzodiazepine receptor modulators
EP0126970A3 (en) * 1983-04-27 1985-11-06 Beecham Group Plc Anxiolytic and anti-depressant thienopyridine derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0223420A1 (en) * 1985-10-18 1987-05-27 Shionogi & Co., Ltd. Condensed imidazopyridine derivatives

Also Published As

Publication number Publication date
EP0168350A3 (en) 1987-09-09
FI852672L (fi) 1986-01-10
PT80777A (en) 1985-08-01
EP0168350B1 (en) 1992-05-06
FI80695B (fi) 1990-03-30
NO852747L (no) 1986-01-10
IE58743B1 (en) 1993-11-03
DK310785A (da) 1986-01-10
ES544954A0 (es) 1987-02-16
FI852672A0 (fi) 1985-07-05
GR851685B (el) 1985-11-26
ES8706674A1 (es) 1987-07-01
PT80777B (pt) 1987-10-20
AU4467585A (en) 1986-01-16
ES551992A0 (es) 1987-07-01
JPS6140285A (ja) 1986-02-26
NO163056B (no) 1989-12-18
ATE75744T1 (de) 1992-05-15
DK168952B1 (da) 1994-07-18
CA1263651A (en) 1989-12-05
DE3585973D1 (de) 1992-06-11
FI80695C (fi) 1990-07-10
HUT38632A (en) 1986-06-30
NO163056C (no) 1990-03-28
NZ212669A (en) 1989-04-26
IL75745A0 (en) 1985-11-29
DK310785D0 (da) 1985-07-08
ZA855126B (en) 1987-03-25
HU198929B (en) 1989-12-28
ES8703462A1 (es) 1987-02-16
IL75745A (en) 1989-05-15
IE851712L (en) 1986-01-09
EP0168350A2 (en) 1986-01-15
AU584906B2 (en) 1989-06-08

Similar Documents

Publication Publication Date Title
DE60021630T2 (de) Tricyclische kondensierte heterocyclische Verbindungen als CRF Antagonisten
DE69304243T2 (de) Chinolin-Verbindungen als Angiotensin-II-Antagoniste
EP0973774B1 (de) 1,5-dihydro-pyrazolo 3,4-d]-pyrimidinon-derivate
DE69310563T2 (de) Kondensierte Imidazopyridinderivate mit psychotropischer Wirkung
EP0944631B1 (de) Neue substituierte pyrazolderivate zur behandlung von herzkreislauferkrankungen
DE69434380T2 (de) Pyridazino-Chinolin Verbindungen
JPH05507092A (ja) ビス―ベンゾまたはベンゾピリドシクロヘプタピペリジン、ピペリジリデンおよびピペラジン化合物および組成物
DD153840A5 (de) Verfahren zur herstellung von neuartigen substituierten pyrazol(1,5-a)pyrimidinen
DE602004003952T2 (de) Substituierte tetrahydrobenzothienopyrimidinamine verbindungen geeignet zur behandlung von hyper-proliferative disorders
DE69732090T2 (de) Indol-2,3-dione-3-oxim derivate
DE2609486C2 (el)
EP0115469B1 (de) Heterocyclisch ankondensierte Pyrazolo(3,4-d)pyridin-3-one
DE69907675T2 (de) Ein substituiertes triazolo-pyridazin-derivat, davon hergestellte arzneimittel
DE69823493T2 (de) Tetrahydropyridoverbindungen
DE60213851T2 (de) Ringannelierte pyrazolderivate
DE3835842A1 (de) Indolocarbazol-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
DD223151A5 (de) Verfahren zur herstellung von 1,6-naphthyridinon-derivaten
US4602014A (en) Ring-fused pyrazolo[3,4-d]-pyridin-3-one derivatives as benzodiazepine receptor modulators
CH656127A5 (de) Substituierte pyrazolochinoline, verfahren zu ihrer herstellung und pharmazeutische praeparate enthaltend diese verbindungen.
DE3780015T2 (de) Kondensierte heterocyclische tetrahydroaminochinolinole und verwandte verbindungen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE60204582T2 (de) Neue heteroaromatische amidderivate von 3beta aminoazabicyclooctanen, verfahren zu ihrer herstellung und ihre therapeutische verwendung
DD210456A5 (de) Verfahren zur herstellung von pyrazolopyridin-verbindungen
WO2001057042A2 (de) 4-pyridyl- und 2,4-pyrimidinyl-substituierte pyrrolderivate und ihre anwendung in der pharmazie
EP0168350B1 (en) Certain ring-fused pyrazolo [3,4-d]-pyridin-3-one derivatives
US4814450A (en) Certain ring-fused pyrazolo[3,4-d]-pyridin-3-one derivatives

Legal Events

Date Code Title Description
A5 Published as prov. exclusive patent
ENJ Ceased due to non-payment of renewal fee